ArticleCureus2025
Spontaneous Resolution of Unexplained Neutropenia in Primary Hyperparathyroidism: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 65-year-old gentleman was referred to our institution through the two-week-wait pathway after presenting with a four-week history of bilateral lymphadenopathy. A lymph node biopsy confirmed the diagnosis of follicular lymphoma, grade III, for which he was treated with six cycles of obinutuzumab and bendamustine. A completion computed tomography scan showed stable appearances of the spleen and stranding in the left iliac chain. Obinutuzumab was continued as maintenance therapy. Despite the completion of lymphoma treatment and without evidence of disease relapse, he developed a persistent neutropenia, leading to recurrent chest infections and oesophageal candidiasis. He underwent multiple bone marrow biopsies to investigate further. During the same timeline, he was concurrently diagnosed with primary hyperparathyroidism (PHPT). Parathyroidectomy was performed following the recommendation from the Endocrine Multidisciplinary Team review, after initial delays due to concerns about operating while neutropenic. Following parathyroidectomy, the hypocalcaemia-related symptoms resolved, and the serum calcium and parathyroid hormone (PTH) levels have returned to normal. Notably, a complete restoration of the neutropenia was observed, along with the recovery of chronic persistent respiratory infections. This case highlights that isolated neutropenia can also be associated with PHPT, providing further evidence, in addition to existing research and similar case reports, that have focused more on anaemia and pancytopenia. Therefore, we recommend investigating refractory neutropenia or pancytopenia with bone profiles, including calcium, phosphate, and PTH levels. Early identification of hyperparathyroidism and prompt referral to the Endocrinology Team can be critical, as surgical intervention can lead to a complete recovery of neutropenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.